Moderna advances Hantavirus Vaccine research after cruise ship outbreak raises global concern
US biotechnology company Moderna has confirmed that it is developing a vaccine against hantavirus with the Vaccine Innovation Center of Korea University College of Medicine, known as VIC-K. The announcement gained attention after a hantavirus outbreak aboard the MV Hondius cruise ship. The ship sailed from Argentina before passengers and crew disembarked in the Canary…